title: The APOA5 Trp19 allele is associated with metabolic syndrome via its association with plasma triglycerides.
abstract: BACKGROUND
  The goal of the present study was to assess the effect of genetic variability at the APOA5/A4/C3/A1 cluster locus on the risk of metabolic syndrome.
  
  
  METHODS
  The APOA5 Ser19Trp, APOA5 -12,238T>C, APOA4 Thr347Ser, APOC3 -482C>T and APOC3 3238C>G (SstI) polymorphisms were analyzed in a representative population sample of 3138 men and women from France, including 932 individuals with metabolic syndrome and 2206 without metabolic syndrome, as defined by the NCEP criteria.
  
  
  RESULTS
  Compared with homozygotes for the common allele, the odds ratio (OR) [95% CI] for metabolic syndrome was 1.30 [1.03-1.66] (p = 0.03) for APOA5 Trp19 carriers, 0.81 [0.69-0.95] (p = 0.01) for APOA5 -12,238C carriers and 0.84 [0.70-0.99] (p = 0.04) for APOA4 Ser347 carriers. Adjustment for plasma triglycerides, (but not for waist girth, HDL, blood pressure or glycemia - the other components of metabolic syndrome) abolished these associations and suggests that triglyceride levels explain the association with metabolic syndrome. There was no association between the APOC3 -482C>T or APOC3 3238C>G polymorphisms and metabolic syndrome. The decreased risk of metabolic syndrome observed in APOA5 -12,238C and APOA4 Ser347 carriers merely reflected the fact that the APOA5 Trp19 allele was in negative linkage disequilibrium with the common alleles of APOA5 -12,238T>C and APOA4 Thr347Ser polymorphisms.
  
  
  CONCLUSIONS
  The APOA5 Trp19 allele increased susceptibility to metabolic syndrome via its impact on plasma triglyceride levels.
authors.affiliation: Institut Pasteur de Lille, INSERM, U744, Université de Lille 2, Lille, France. jean.dallongeville@pasteur-lille.fr
authors.forename: Jean
authors.initials: J
authors.lastname: Dallongeville
authors.forename: Dominique
authors.initials: D
authors.lastname: Cottel
authors.forename: Aline
authors.initials: A
authors.lastname: Wagner
authors.forename: Pierre
authors.initials: P
authors.lastname: Ducimetière
authors.forename: Jean-Bernard
authors.initials: JB
authors.lastname: Ruidavets
authors.forename: Dominique
authors.initials: D
authors.lastname: Arveiler
authors.forename: Annie
authors.initials: A
authors.lastname: Bingham
authors.forename: Jean
authors.initials: J
authors.lastname: Ferrières
authors.forename: Philippe
authors.initials: P
authors.lastname: Amouyel
authors.forename: Aline
authors.initials: A
authors.lastname: Meirhaeghe
mesh_terms: D000328:Adult; D000483:Alleles; D000072040:Apolipoprotein A-V; D001054:Apolipoproteins A / Q000235:genetics*; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000235:genetics; D005260:Female; D005602:France; D020022:Genetic Predisposition to Disease; D005838:Genotype; D006801:Humans; D015810:Linkage Disequilibrium; D008297:Male; D024821:Metabolic Syndrome / Q000097:blood / Q000235:genetics*; D008875:Middle Aged; D016017:Odds Ratio; D020641:Polymorphism, Single Nucleotide; D014280:Triglycerides / Q000097:blood*
chemical_list: C437704:APOA5 protein, human; D000072040:Apolipoprotein A-V; D001054:Apolipoproteins A; D014280:Triglycerides
references.citation: Cardiol Rev. 2005 Nov-Dec;13(6):322-7
references.pmid: 16708441
references.citation: J Med Genet. 2008 Jan;45(1):22-8
references.pmid: 17766366
references.citation: Genetics. 1964 Jan;49(1):49-67
references.pmid: 17248194
references.citation: Science. 2001 Oct 5;294(5540):169-73
references.pmid: 11588264
references.citation: J Biol Chem. 2005 Jun 3;280(22):21553-60
references.pmid: 15774484
references.citation: Arterioscler Thromb Vasc Biol. 2004 Jul;24(7):1297-302
references.pmid: 15117734
references.citation: Hum Mol Genet. 2002 Aug 15;11(17):2015-23
references.pmid: 12165563
references.citation: Pathol Oncol Res. 2007;13(3):243-7
references.pmid: 17922054
references.citation: Am J Hum Genet. 1997 Jan;60(1):143-52
references.pmid: 8981957
references.citation: Clin Chem Lab Med. 2005;43(9):897-902
references.pmid: 16176166
references.citation: Eur Heart J. 2007 Apr;28(7):850-6
references.pmid: 17403720
references.citation: Circ J. 2008 Jan;72(1):40-3
references.pmid: 18159097
references.citation: BMC Med Genet. 2006 Oct 10;7:76
references.pmid: 17032446
references.citation: Atherosclerosis. 1999 Jul;145(1):197-205
references.pmid: 10428311
references.citation: Cardiovasc Res. 1999 Jun;42(3):783-93
references.pmid: 10533619
references.citation: J Biol Chem. 2004 Jul 2;279(27):27941-7
references.pmid: 15090553
references.citation: Lancet. 2005 Sep 24-30;366(9491):1059-62
references.pmid: 16182882
references.citation: Heredity (Edinb). 1996 Apr;76 ( Pt 4):377-83
references.pmid: 8626222
references.citation: Clin Genet. 2002 Sep;62(3):208-13
references.pmid: 12220435
references.citation: Atherosclerosis. 2007 Apr;191(2):298-304
references.pmid: 16806226
references.citation: Curr Opin Lipidol. 2005 Apr;16(2):153-66
references.pmid: 15767855
references.citation: Hum Mol Genet. 2002 Nov 15;11(24):3039-46
references.pmid: 12417525
references.citation: Arterioscler Thromb Vasc Biol. 1996 Feb;16(2):281-8
references.pmid: 8620344
references.citation: Curr Opin Lipidol. 2004 Jun;15(3):239-46
references.pmid: 15166778
references.citation: Biochem Biophys Res Commun. 2004 Jun 25;319(2):397-404
references.pmid: 15178420
references.citation: Ann Hum Genet. 2004 Mar;68(Pt 2):165-77
references.pmid: 15008795
references.citation: Mol Cell Biol. 2005 Feb;25(4):1537-48
references.pmid: 15684402
references.citation: J Lipid Res. 2007 Dec;48(12):2614-21
references.pmid: 17768309
references.citation: Hum Mol Genet. 2002 Nov 15;11(24):3031-8
references.pmid: 12417524
references.citation: J Clin Epidemiol. 1988;41(2):105-14
references.pmid: 3335877
references.citation: Can J Cardiol. 2000 Jun;16(6):779-89
references.pmid: 10863169
references.citation: Diabetes. 1988 Dec;37(12):1595-607
references.pmid: 3056758
references.citation: Diabetes. 2005 Oct;54(10):3043-8
references.pmid: 16186413
references.citation: J Clin Endocrinol Metab. 2003 Oct;88(10):4862-6
references.pmid: 14557466